Lyra Therapeutics Ownership | Who Owns Lyra Therapeutics?


OverviewForecastRevenueFinancialsChart

Lyra Therapeutics Ownership Summary


Lyra Therapeutics is owned by 24.00% institutional investors, 0.83% insiders, and 75.17% retail investors. Perceptive advisors is the largest institutional shareholder, holding 19.40% of LYRA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.51% of its assets in Lyra Therapeutics shares.

LYRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLyra Therapeutics24.00%0.83%75.17%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors12.76M19.40%$1.61M
Blackrock funding, inc. /de3.11M4.75%$641.86K
Blackrock2.83M4.42%$783.05K
Vanguard group1.79M2.73%$368.21K
Samsara biocapital1.39M2.11%$175.57K
Ikarian capital1.06M1.61%$133.65K
Geode capital management885.97K1.35%$182.89K
Morgan stanley811.75K1.27%$224.61K
Goldman sachs group555.51K0.85%$114.66K
Adar1 capital management533.20K0.81%$67.34K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Perceptive advisors12.76M0.06%$1.61M
Samsara biocapital1.39M0.03%$175.57K
Ikarian capital1.06M0.02%$133.65K
Adar1 capital management533.20K0.01%$67.34K
Abel hall17.65K0.00%$3.64K
Boothbay fund management233.99K0.00%$48.30K
Caption management246.60K0.00%$68.23K
Tower research capital llc (trc)39.78K0.00%$8.20K
Two sigma advisers, lp385.50K0.00%$79.57K
Two sigma investments, lp210.00K0.00%$43.34K

Top Buyers

HolderShares% AssetsChange
Blackrock2.83M-2.68M
Morgan stanley811.75K-747.35K
Ubs group424.96K-400.05K
Caption management246.60K0.00%246.60K
Bnp paribas arbitrage, snc244.92K-244.92K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---2.82M
Point72 asset management---2.74M
Vr adviser---2.58M
Pura vida investments---1.41M
Rosalind advisors---1.03M

New Positions

HolderShares% AssetsChangeValue
Caption management246.60K0.00%246.60K$68.23K
Bnp paribas arbitrage, snc244.92K-244.92K$50.55K
Abel hall17.65K0.00%17.65K$3.64K
Proshare advisors13.63K-13.63K$2.81K
Cwm5.37K-5.37K$1.00K

Sold Out

HolderChange
Farther finance advisors-38.00
Northwestern mutual wealth management-70.00
Capital performance advisors llp-533.00
Advisor group-878.00
Macquarie group-1.38K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20255-90.74%15,783,037-41.30%241.42%1-96.43%1-91.67%
Dec 31, 202454-12.90%26,885,924-17.35%411.66%28-12.50%12-14.29%
Sep 30, 20246115.09%32,528,511-0.62%491.90%3110.71%147.69%
Jun 30, 202453-35.37%32,730,433-28.15%510.61%28-47.17%13-7.14%
Mar 31, 20248230.16%45,556,2217.55%911.65%5317.78%14366.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF992.54K1.51%2.00
iShares Russell 2000 Growth ETF408.38K0.62%-
Fidelity Small Cap Index317.10K0.48%-
Fidelity Extended Market Index274.53K0.42%50.00K
Vanguard Russell 2000 ETF240.12K0.36%13.49K
Russell 3000 Screened Index Composite186.70K0.29%186.70K
Spartan Total Market Index Pool E140.13K0.21%-
Spartan Total Market Index Pool G140.13K0.21%-
NT R2000 Growth Index Fund - L136.01K0.21%117.58K
Northern Trust Russell 2000 Growth Index136.01K0.21%117.58K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2023Waksal Harlan Executive ChairBuy$74.09K
May 31, 2023NBVM GP, LLC-Buy$981.37K
May 31, 2023NBVM GP, LLC-Buy$481.01K
May 31, 2023NBVM GP, LLC-Buy$1.61M
May 31, 2023NBVM GP, LLC-Buy$2.92M

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

LYRA Ownership FAQ


Who Owns Lyra Therapeutics?

Lyra Therapeutics shareholders are primarily institutional investors at 24.00%, followed by 0.83% insiders and 75.17% retail investors. The average institutional ownership in Lyra Therapeutics's industry, Biotech Stocks , is 63.96%, which Lyra Therapeutics falls below.

Who owns the most shares of Lyra Therapeutics?

Lyra Therapeutics’s largest shareholders are Perceptive advisors (12.76M shares, 19.40%), Blackrock funding, inc. /de (3.11M shares, 4.75%), and Blackrock (2.83M shares, 4.42%). Together, they hold 28.57% of Lyra Therapeutics’s total shares outstanding.

Does Blackrock own Lyra Therapeutics?

Yes, BlackRock owns 4.42% of Lyra Therapeutics, totaling 2.83M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 783.06K$. In the last quarter, BlackRock increased its holdings by 2.68M shares, a 1762.82% change.

Who is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Perceptive advisors is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 12.76M Lyra Therapeutics shares, valued at 1.61M$.

Who is the top mutual fund holder of Lyra Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Lyra Therapeutics shares, with 1.51% of its total shares outstanding invested in 992.54K Lyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools